Seqens Seqens

X

Find Radio Compass News for MolPort-001-785-697

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

USP

JP

Other Listed Suppliers

SERVICES

0

https://www.reuters.com/article/us-usa-executions-exclusive/exclusive-while-battling-opioid-crisis-u-s-government-weighed-using-fentanyl-for-executions-idUSKCN1VY0YS?feedType=RSS&feedName=healthNews

Jonathan Allen REUTERS
13 Sep 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206677

FDA
29 Nov 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203619

FDA
15 Nov 2017

http://www.seattletimes.com/life/pets/evangers-recalls-canned-dog-food-after-deadly-drug-found-washington-pet-dies/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_seattle-news

SEATTLE TIMES
08 Feb 2017

https://www.pharmacompass.com/pdf/news/mylan-institutional-generic-pentobarbital-sodium-approved-in-us-1464261670.pdf

FDA
24 May 2016

http://www.fiercepharma.com/story/dutch-pension-fund-pulls-out-mylan-amid-death-penalty-drug-concerns/2015-08-31

Emily Wasserman FIERCE PHARMA
31 Aug 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY